Patients | Drug regimen at the time of the study | Duration of virologic suppression (month) | Plasma HIV-1 RNA level (copies/ml) | CD4+ T cell count (cells/μl) |
---|---|---|---|---|
1 | naive | 5,634 | 264 | |
2 | naive | 21,580 | 291 | |
3 | naive | 1,246 | 460 | |
4 | naive | 72,539 | 315 | |
5 | naive | 42,536 | 574 | |
6 | naive | 2,156,097 | 656 | |
7 | pti | 184,713 | 271 | |
8 | pti | 163,435 | 406 | |
9 | pti | 11,869 | 697 | |
10 | naive | <50 | 945 | |
11 | pti | 2,276 | 493 | |
12 | npti | 40,000 | 322 | |
13 | 3TC+ABC+NVP | 1,140 | 998 | |
14 | 3TC+ABC+NVP | 48 | <50 | 448 |
15 | ABC+3TC+NFV | 34 | <50 | 185 |
16 | ABC+3TC+NVP | 60 | <50 | 460 |
17 | 3TC+EFV+TNV | 39 | <50 | 892 |
18 | AZT+ABC+3TC+LVP/RTV | 1 | <50 | 479 |
19 | 3TC+TNV+SQV/RTV | 1 | <50 | 1,151 |
20 | 3TC+TNV+NVP | 67 | <50 | 468 |
21 | TNV+ABC | 39 | <50 | 527 |
22 | 3TC+ABC+LVP/RTV | 19 | <50 | 63 |
23 | AZT+3TC+DDI | 68 | <50 | 995 |